King's fever dies down

King's fever dies down

His Majesty the King’s fever has dropped, but his breathing is sometimes faster than usual, though pulse and blood pressure remain normal, the Royal Household Bureau said Sunday.

According to the 19th statement released Sunday, His Majesty had had a fever for up to two weeks, with more saliva and phlegm, although his blood pressure was normal. The King sometimes had rapid breathing and lower blood oxygen levels than normal.

A chest X-ray showed inflammation in the lower part of the lungs. Inflammation was also found in his right knee. The result of blood checks showed he had an infection in his blood. 

The team of royal physicians gave antibiotics to His Majesty intravenously, along with medicine to dissolve phlegm and oxygen.

Later, another chest X-ray showed no signs of inflammation while the inflammation in his right knee began to subside. However, minor inflammation of the left lung was detected on Jan 5 and the doctors administered a higher dose of antibiotics as well as oxygen. 

Currently, the King’s fever has declined but his breathing is occasionally faster than normal, while the pulse and blood pressure are normal, the bureau said.

His Majesty has been receiving treatment at Siriraj since returning to the hospital from Klai Kangwon Palace in Hua Hin district, Prachuap Khiri Khan province, on May 31 last year. 


Do you like the content of this article?

President Biden to attend Asean-US summit on Tuesday

BANDAR SERI BEGAWAN: US President Joe Biden will attend a meeting with the Association of Southeast Asian Nations (Asean) on Tuesday, the US embassy in Brunei told Reuters.

25 Oct 2021

UN: World greenhouse gas levels hit record last year

GENEVA: Greenhouse gas concentrations hit a record last year and the world is "way off track" on climate goals, the UN weather agency said on Monday, showing the scale of the task facing governments scrambling to avert dangerous levels of warming.

25 Oct 2021

Indonesia in talks to buy Merck's Covid-19 antiviral pill

JAKARTA: Indonesia is "finalising" a deal with Merck & Co to procure its experimental antiviral pills, named molnupiravir, to treat Covid-19 ailments, Health Minister Budi Gunadi Sadikin said on Monday.

25 Oct 2021